S&P 500
(-0.18%) 5 026.61 points
Dow Jones
(0.19%) 37 887 points
Nasdaq
(-0.02%) 15 654 points
Oil
(-2.03%) $80.27
Gas
(-3.52%) $1.921
Gold
(0.41%) $2 312.30
Silver
(0.14%) $26.69
Platinum
(2.01%) $967.25
USD/EUR
(-0.09%) $0.936
USD/NOK
(-0.13%) $11.08
USD/GBP
(0.03%) $0.801
USD/RUB
(-0.12%) $93.34

实时更新: Qiagen NV [QGEN]

交易所: NYSE 部门: Healthcare 工业: Diagnostics & Research
最后更新时间1 May 2024 @ 22:49

0.06% $ 42.36

Live Chart Being Loaded With Signals

Commentary (1 May 2024 @ 22:49):

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories...

Stats
今日成交量 156 177
平均成交量 1.07M
市值 9.38B
EPS $0.550 ( 2024-04-29 )
下一个收益日期 ( $0.440 ) 2024-06-21
Last Dividend $1.087 ( 2017-01-25 )
Next Dividend $0 ( N/A )
P/E 27.68
ATR14 $0.0320 (0.08%)

音量 相关性

長: -0.07 (neutral)
短: -1.00 (very strong negative)
Signal:(49.572) Neutral

Qiagen NV 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Qiagen NV 相关性 - 货币/商品

The country flag 0.23
( neutral )
The country flag -0.17
( neutral )
The country flag 0.00
( neutral )
The country flag 0.17
( neutral )
The country flag 0.02
( neutral )

Qiagen NV 财务报表

Annual 2023
营收: $1.97B
毛利润: $1.22B (62.23 %)
EPS: $1.540
FY 2023
营收: $1.97B
毛利润: $1.22B (62.23 %)
EPS: $1.540
FY 2022
营收: $2.14B
毛利润: $1.38B (64.65 %)
EPS: $1.920
FY 2021
营收: $2.25B
毛利润: $1.45B (64.43 %)
EPS: $2.25

Financial Reports:

No articles found.

Qiagen NV Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Qiagen NV Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.37 - Stable (12.52%)
Information
First Dividend $0.00208 2002-12-26
Last Dividend $1.087 2017-01-25
Next Dividend $0 N/A
Payout Date 2017-01-31
Next Payout Date N/A
# dividends 2 --
Total Paid Out $1.089 --
Avg. Dividend % Per Year 0.00% --
Score 2.39 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.37
Div. Directional Score 7.23 --
Next Divdend (Est)
(2031-04-04)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
2.39
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
2002 $0.00208 0.01%
2003 $0 0.00%
2004 $0 0.00%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $1.087 3.71%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
ORC Dividend Royal 2023-11-29 Monthly 12 9.23% 8.50
NCZ Dividend Royal 2024-02-09 Monthly 22 7.79% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1741.5006.539.79[0 - 0.5]
returnOnAssetsTTM0.05581.2008.149.77[0 - 0.3]
returnOnEquityTTM0.09301.500-0.0782-0.117[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.9900.8005.054.04[1 - 3]
quickRatioTTM1.4580.8006.134.90[0.8 - 2.5]
cashRatioTTM0.6191.5007.6710.00[0.2 - 2]
debtRatioTTM0.251-1.5005.82-8.74[0 - 0.6]
interestCoverageTTM8.731.0007.887.88[3 - 30]
operatingCashFlowPerShareTTM2.082.009.3110.00[0 - 30]
freeCashFlowPerShareTTM1.3402.009.3310.00[0 - 20]
debtEquityRatioTTM0.402-1.5008.39-10.00[0 - 2.5]
grossProfitMarginTTM0.6431.0002.622.62[0.2 - 0.8]
operatingProfitMarginTTM0.2371.0007.267.26[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3001.0009.459.45[0.2 - 2]
assetTurnoverTTM0.3210.800-1.191-0.953[0.5 - 2]
Total Score10.09

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM27.461.0007.330[1 - 100]
returnOnEquityTTM0.09302.50-0.0503-0.117[0.1 - 1.5]
freeCashFlowPerShareTTM1.3402.009.5510.00[0 - 30]
dividendYielPercentageTTM3.121.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM2.082.009.3110.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.4881.500-0.07890[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2341.0006.660[0.1 - 0.5]
Total Score4.37

Qiagen NV

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。